Bluechiip (BCT.AX) Aktie Kurs

Bluechiip Kurs

ASX·LUKKET
0
​
Markedet lukket

Omsætningen er vokset med 30,4 % om året de seneste 12 år til 484.700,00 AUD. Bluechiips nettoavance ligger på -1.199,3 %, op fra -1.910,5 % for flere år siden.

Bluechiip aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Bluechiip aktie og aktieanalyse

Bluechiip Ltd er et australsk selskab, der blev grundlagt i 2003. Virksomheden beskæftiger sig med udvikling og produktion af avancerede ID-sporingssystemer og temperaturovervågningsløsninger til forskellige anvendelser. Bluechiips produkter er primært designet til brug i krævende videnskabelige og kliniske applikationer. Selskabet har i de senere år udvidet sin tilstedeværelse til forskellige sektorer, herunder biobankering, farmaceutisk industri, diagnostik samt landbrugs-, miljø- og fødevareovervågning. Bluechiips produkter anvendes i forskningslaboratorier, hospitaler og klinikker, biobanker, farmaceutiske virksomheder og store produktionsfaciliteter. Selskabets mest kendte produkter inkluderer chip-teknologi, som tilbyder en integreret, trådløs løsning til ID-chipsporing og temperaturovervågning. Et andet produkt er barcodesporingssystemet, som gør det muligt for brugerne effektivt at spore lagerbeholdning, identificere materialer og fastslå deres placering. Bluechiips produkter nyder stor anerkendelse hos en række virksomheder og organisationer, herunder NIST, University of California, Royal Melbourne Hospital og mange andre. Selskabets mål er at udvide fordelene ved sine unikke teknologier inden for forskellige applikationer og tilbyder forskning- og udviklingstjenester til at skabe skræddersyede løsninger til specifikke krav. Bluechiip forbedrer og udvider løbende sit sortiment af produkter og tjenester for at tilbyde kunder verden over innovative sporings- og temperaturovervågningsløsninger. Bluechiips produkter efterspørges globalt på grund af deres pålidelighed og unikke teknologi.

Hyppigt stillede spørgsmål om Bluechiip-aktien

Bluechiip Ltd is an innovative technology company specializing in advanced tracking solutions. Founded in 2005, Bluechiip has revolutionized the way temperature-sensitive assets are monitored and tracked. The company's breakthrough technology combines both passive RFID and MEMS technologies to provide highly accurate and reliable identification of assets in extreme conditions. Bluechiip's patented product, the Bluechiip Smart, is leading the industry in healthcare, life sciences, and sample tracking. With a strong focus on innovation and continuous improvement, Bluechiip Ltd is committed to delivering cutting-edge tracking solutions to meet the evolving needs of its customers.

The business model of Bluechiip Ltd revolves around providing innovative tracking solutions for various industries. The company specializes in developing and commercializing advanced tracking technologies using its proprietary chip and software platform. Bluechiip's unique microchips enable real-time and robust tracking of valuable assets, such as biological samples, electronic components, and medical devices. By incorporating wireless communication and temperature sensing capabilities, Bluechiip's tracking solutions offer accurate monitoring and improved efficiency in inventory management. The company's technology finds applications in healthcare, pharmaceuticals, cryogenic storage, and logistics sectors, ensuring traceability and enhancing supply chain management. Bluechiip Ltd aims to deliver reliable and secure tracking solutions to facilitate seamless operations and safeguard valuable assets for its clients.

Bluechiip Ltd is primarily active in the healthcare and life sciences industries.

The main competitors of Bluechiip Ltd in the market include companies like Zymergen Inc., NanoString Technologies Inc., and Fluidigm Corporation.

Bluechiip Ltd has achieved several significant milestones. The company successfully developed its innovative wireless tracking solution, which combines a unique microchip with a passive RFID tag. Bluechiip's technology aims to revolutionize the storage and monitoring of critical biological samples, such as those used in healthcare and pharmaceutical industries. The company has also formed strategic partnerships with leading organizations in various sectors, including healthcare and biobanking, to showcase the potential of its solution. Bluechiip continues to enhance its product portfolio and expand its market reach, positioning itself as a key player in the field of advanced tracking and monitoring systems.

Bluechiip Ltd is primarily present in Australia.

Bluechiip Ltd represents values of innovation, reliability, and sustainability in its corporate philosophy. The company focuses on developing and commercializing advanced tracking solutions using its unique and patented technology. Bluechiip's solution provides a highly reliable, tamper-proof, and cost-effective method for tracking and monitoring critical samples, such as those used in healthcare, research, and logistics industries. With a commitment to continuous improvement and a customer-centric approach, Bluechiip aims to provide exceptional solutions that improve efficiency, reduce errors, and enhance overall operational effectiveness. As a result, Bluechiip Ltd sets itself apart as a leading provider of cutting-edge tracking technology solutions.

Bluechiip-aktien (BCT.AX) er noteret på 2 børser, herunder: ASX (BCT.AX), Frankfurt (1BL.F).

Bluechiip Ltd is a leading provider of innovative solutions in the cryo-biology industry. The company specializes in developing sample management systems based on the unique Bluechiip technology to improve efficiency and accuracy in cryo-biology. The Bluechiip technology combines RFID and MEMS technology to identify samples even under extreme conditions of -196 degrees Celsius. It offers various products and solutions tailored to the needs of customers, including a sample management system with automatic sample tracking and real-time data monitoring. Bluechiip also partners with other companies in the cryo-biology industry to expand its product portfolio and develop new applications. The company invests in research and development to improve its product portfolio and develop new technologies. It focuses on markets such as biobanks, research institutions, cell therapy, clinical trials, and bioproduction and supply chain management. The Bluechiip technology provides enhanced data capture, increased security, and more efficient sample management solutions for the cryo-biology industry.

forventet-omsætningen for Bluechiip er 8,29 Mio. AUD. Dette tal er baseret på aktuelle finansielle data og afspejler virksomhedens forretningsydeevne.

Overskuddet kan for øjeblikket ikke beregnes for Bluechiip.

P/E-forholdet kan ikke beregnes for Bluechiip i øjeblikket.

P/S-forholdet kan ikke beregnes for Bluechiip i øjeblikket.

AlleAktien-kvalitetsscore for Bluechiip er 4/10.

ISIN for Bluechiip er AU000000BCT7. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Bluechiip er A1JFYH. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Bluechiip er BCT.AX. Tickersymbolet bruges til at handle Bluechiip-aktier på børsen.

Fair værdiTerminal
148.30 AUD
Over-/underværdieringTerminal
Fair værdieret
Industri
Elektronisk Udstyr, Instrumenter & Komponenter
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
69.242,86 AUD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Hjemmeside bluechiip.com
Land
Australien
Valuta
AUD
Børsintroduktion
14. feb. 2011
ISIN
AU000000BCT7
CUSIP
Q1625L108
SEDOL
B68G4C1
Markedsværdi
3,62 Mio. AUDMicro Cap
52-ugers interval
AAQS
4 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2025
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
5,11
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-404,63 %
Sidst opdateret 16. okt. 2026, 00.38

Bluechiip Peer Group

Bluechiip Ticker

ASX · BCT.AXFRANKFURT · 1BL.F

Bluechiip FIGI

BCT:AU · BBG00178NTB1BCT:AT · BBG00195VNX5BCT:AH · BBG002F3RTZ11BL:GR · BBG00QRDWKT31BL:GF · BBG00QRDWKV0BCT2EUR:XS · BBG00QRP0MM4BCT2EUR:XH · BBG00QRP0MQ0BCT2EUR:XF · BBG00QRP0MS8BCT2EUR:XE · BBG00QRP0MV4BCT2EUR:XJ · BBG00QRP0MW3BCT2EUR:XL · BBG00QRP0MX2BCT2EUR:XG · BBG00QRP0MY1

Alle fundamentale data om Bluechiip i deep dive

Vores aktieanalyse af Bluechiip-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Bluechiip. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: